What is Septerna, Inc.'s short- term investments?

Septerna, Inc. (SEPN) reported short- term investments of $275.8M in Q1 2026.

How has Septerna, Inc.'s short- term investments changed year-over-year?

Septerna, Inc.'s short- term investments increased by 119.0% year-over-year, from $125.96M to $275.8M.

Septerna, Inc. SEPN Short- term Investments

Short- term Investments at other companies

Maze Therapeutics, Inc. Common StockMAZE

——

Apogee Therapeutics, Inc.APGE

——

Enliven TherapeuticsELVN

——

Scholar RockSRRK

——

Other financials

Income statement

See full

Revenue$26.5M+12,011%

Operating income-$13.3M+48.7%

Net income-$8.6M+59.8%

EPS (diluted)-$0.19+61.2%

Balance sheet

See full

Cash & equivalents$71.6M-65.9%

Total debt$23.1M-7.7%

Total equity$378.5M+195%

Total assets$569.7M+31.3%

Cash flow

See full

Operating cash flow-$25.6M-9.8%

CapEx$832.0K+118%

Free cash flow-$26.5M-11.5%

Valuation

See full

Market cap$1.62B+319%

Profitability

See full

Operating margin-77.1%-38.4pp

Net margin-49.9%-24.9pp

FCF margin467.9%+243pp

Returns & leverage

See full

Return on equity-12.2%—

Debt / equity0.1×—

Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Septerna, Inc.'s short- term investments?: Septerna, Inc. (SEPN) reported short- term investments of $275.8M in Q1 2026.
How has Septerna, Inc.'s short- term investments changed year-over-year?: Septerna, Inc.'s short- term investments increased by 119.0% year-over-year, from $125.96M to $275.8M.